|
Originally published In Press as doi:10.1074/jbc.M208576200 on September 25, 2002
J. Biol. Chem., Vol. 277, Issue 49, 46864-46870, December 6, 2002
Complex Nuclear Localization Signals in the Matrix Protein of
Vesicular Stomatitis Virus*
Doreen R.
Glodowski,
Jeannine M.
Petersen , and
James E.
Dahlberg§
From the Department of Biomolecular Chemistry, University of
Wisconsin, Madison, Wisconsin 53706-1532
Received for publication, August 21, 2002, and in revised form, September 20, 2002
 |
ABSTRACT |
The matrix (M) protein of vesicular stomatitis
virus (VSV) functions from within the nucleus to inhibit bi-directional
nucleocytoplasmic transport. Here, we show that M protein can be
imported into the nucleus by an active transport mechanism, even though
it is small enough (~27 kDa) to diffuse through nuclear pore
complexes. We map two distinct nuclear localization signal
(NLS)-containing regions of M protein, each of which is capable of
directing the nuclear localization of a heterologous protein. One of
these regions, comprising amino acids 47-229, is also sufficient to
inhibit nucleocytoplasmic transport. Two amino acids that are conserved
among the matrix proteins of vesiculoviruses are important for nuclear
localization, but are not essential for the inhibitory activity
of M protein. Thus, different regions of M protein function for nuclear
localization and for inhibitory activity.
 |
INTRODUCTION |
In eukaryotic cells, molecular transport between the nucleus and
cytoplasm occurs through nuclear pore complexes
(NPCs),1 large proteinacious
structures that span the nuclear envelope (for reviews, see Refs. 1 and
2). Small molecules can diffuse through NPCs, but larger molecules must
be actively transported. Active transport through NPCs is mediated by
receptor proteins (also known as importins, exportins and transportins,
or karyopherins), which interact with localization signals on cargo
molecules, RanGTP, and proteins of the NPC (nucleoporins or Nups) (for
reviews, see Refs. 3-5).
Nuclear localization signals (NLSs) are amino acid sequences that
promote the active nuclear import of proteins, even when these proteins
are small enough to diffuse through the NPC (for example, see Refs. 6
and 7). A wide variety of sequences have been identified that can
function as NLSs, the best characterized of which are the highly basic
mono- and bi-partite NLSs of SV40 T antigen and nucleoplasmin,
respectively (for review, see Ref. 8). In addition, many other NLSs
have been identified that differ from these sequences with respect to
size and/or highly basic character (for example, see Refs. 9-12).
Thus, it is difficult to predict the identity of an NLS without
empirical evidence.
Previously, we and others have shown that the matrix (M) protein of
vesicular stomatitis virus (VSV) inhibits active nucleocytoplasmic transport (13-15). In the absence of other viral components, M protein
inhibits nuclear export of mRNAs, snRNAs, and rRNAs, but not tRNAs,
and slows nuclear import of proteins containing highly basic mono- and
bi-partite NLSs (13, 14). The M proteins from two other
vesiculoviruses, chandipura virus and spring viremia carp virus, also
have inhibitory activity (16).
Earlier work from our laboratory demonstrated that M protein must be
present in the nucleus to inhibit nucleocytoplasmic transport and that
this inhibitory activity correlates with the ability of M protein to
associate with NPCs (14). These observations are consistent with the
findings that M protein associates with the intranuclear nucleoporin
Nup98, and that this association is important for the inhibitory
activity of M protein (15, 17). The mechanism by which M protein gains
access to Nup98 or other potential nuclear targets remains to be
determined. Even though the size of M protein (~27 kDa) is below the
diffusion limit of the NPC (4), nuclear entry might occur by active import.
Here, we show that M protein can localize to the nucleus by an active
import mechanism. We identify two regions of M protein that are each
sufficient to direct the nuclear localization of a heterologous
protein. These regions share a common sequence of 10 amino acids. We
show that the region spanning amino acids 47-229 contains an NLS and
is sufficient for the inhibitory activity of M protein. Finally, we
identify two amino acids within M-(47-229) that are important for
nuclear localization, but are not necessary for inhibitory activity.
Thus, the interactions between M protein and cellular protein(s) that
occur during nuclear localization are likely to be different from
interactions involved in the inhibitory activity of M protein.
 |
EXPERIMENTAL PROCEDURES |
Construction of GFP3-M Protein DNA Plasmids--
The
pEGFP-C3 vector encoding three tandem copies of GFP
(pEGFP3-C3) was kindly provided by Y. Lazebnik (Cold Spring
Harbor Laboratory). The reading frame within the multiple cloning site of pEGFP3-C3 was shifted by generating a double-stranded
DNA fragment for insertion into the SacII site using the
following complementary oligonucleotides: 5'-GGGCTGCAGAGATCTCCGC-3' and
5'-GGAGATCTCTGCAGCCCGC-3'. Oligonucleotides were gel-purified,
phosphorylated using T4 DNA kinase (Promega), annealed, and ligated
into pEGFP3-C3 vector that had been digested with
SacII. Correct orientation of the insert was confirmed by
DNA sequencing. The resulting plasmid, pEGFP3-C1, was used
as the vector for all constructs encoding GFP3-M fusion proteins.
To make pEGFP3-M-(1-229), a DNA fragment encoding M
protein was released from pEGFP-C1-OM (16) by BamHI
digestion. This fragment was ligated into pEGFP3-C1 that
had also been digested with BamHI. All truncations of M
protein for ligation into pEGFP3-C1 were made by PCR using
pGEX-2T-OM (14) as template (see Table I
for oligonucleotides). PCR products were digested with Bam H1 and
ligated into pEGFP3-C1 that had also been digested with BamHI. Correct orientation and sequence of all clones was
confirmed by DNA sequencing.
View this table:
[in this window]
[in a new window]
|
Table I
Oligonucleotides used to generate PCR products for ligation into
pEGFP3-C1 vector
For each oligonucleotide pair, the 5'-oligonucleotide is listed first,
followed by the 3'-oligonucleotide.
|
|
Construction of GST-HA-M Protein DNA Plasmids--
To make a
vector encoding GST with an HA epitope tag fused to the C terminus, PCR
was done using the vector pGEX-2T (Amersham Biosciences) as template,
and the following primers (5' and 3', respectively):
5'-GTCTATGGCCATCATACGTTA-3' and
5'-CGGGATCCAAGAGCGTAATCTGGAACATCGTATGGGTAACGCGGAACCAGATCCG-3'. The
resulting PCR product, encoding a carboxyl-terminal portion of GST with
the HA epitope tag, was digested with BalI and
BamHI. The pGEX-2T vector was also digested with
BalI and BamHI. The gel-purified vector fragment
of pGEX-2T was ligated to the PCR product to generate the vector
pGEX-2T-HA. The presence and orientation of the insert was confirmed by
DNA sequencing.
To make a plasmid encoding GST-HA-M-(1-229), a DNA fragment encoding
the M protein was released from pEGFP-C1-OM (16) by digestion with
BamHI. This fragment was ligated into the vector pGEX-2T-HA
that had also been digested with BamHI. A construct encoding
GST-HA-M-(47-229) was made by ligating the
BamHI-digested PCR product coding for M-(47-229) (see
above) into BamHI-digested pGEX-2T-HA vector. DNA sequencing
was done to confirm the orientation and sequence of inserts. Activity
assays (described below) confirmed that the presence of the HA epitope
tag had no detectable effect on the inhibitory activity of the M protein.
Mutagenesis--
Point mutations within M protein were made
using the QuikChangeTM site-directed mutagenesis kit (Stratagene). To
generate constructs encoding mutant GFP3-M fusion proteins
for transient transfection, the following templates were used:
pEGFP3-M-(1-229), pEGFP3-M-(47-229), and
pEGFP3-M-(23-57). To generate constructs encoding mutant
GST-HA fusion proteins for overexpression in Escherichia
coli, pGEX-2T-HA-M-(1-229) and pGEX-2T-HA-M-(47-229) were used
as templates. In all cases, the presence of mutations was confirmed by
DNA sequencing.
GST-HA-M Protein Purification--
For production of recombinant
proteins, all plasmids were transformed into E. coli BL21
cells. Cells were grown overnight at 37 °C in LB medium containing
ampicillin (50 µg/ml). Overnight cultures were used to inoculate
fresh LB-amp to an OD600 of 0.04. Cultures were grown at
room temperature to an OD600 of ~0.6 and then induced for
8 h with 1 mM
isopropyl-1-thio- -D-galactopyranoside. Cells were
harvested and protein was affinity-purified as previously described
(14).
Analysis of RNA Export in Xenopus laevis
Oocytes--
Preparation and injection of stage VI X. laevis oocytes was as described (14). Purified GST-HA-M proteins
(~100 µg/ml) were injected into the nucleus (12 nl) or into the
cytoplasm (24 nl) 1 h prior to injection of RNA export substrates.
A mixture of in vitro-synthesized (18)
32P-labeled RNAs, which contained ~5 fmol of each species
of RNA, was injected into the oocyte nuclei (12 nl). To control for the accuracy of injection and dissection, all injected samples included blue dextran, and the RNA mixture contained U3 snoRNA, which is not
exported from the nucleus (19). At indicated time points, oocytes were
manually dissected into cytoplasmic and nuclear fractions. Total RNAs
were isolated from each fraction and analyzed by denaturing PAGE and
autoradiography as previously described (20).
Antibodies and Western Blotting--
Mouse monoclonal anti-GFP
antibodies (Santa Cruz Biotechnology) were used for Western blots. HeLa
cell extracts were fractionated by SDS-PAGE, and proteins were
transferred to ImmobilonTM-P polyvinylidene difluoride membranes
(Millipore). Membranes were probed with antibodies (1:250) in TBS-T (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, 0.25% Tween 20) containing 5% powdered milk
(Carnation) and developed using LumiGLO® (KPL).
Transfections--
One day prior to performing transient
transfections, a 6-well tissue culture plate containing coverslips was
seeded with 4 × 105 HeLa cells per well.
Transfections were done according to the Invitrogen protocol, using 1 µg of DNA and 8 µl of LipofectAMINETM reagent (Invitrogen Life Technologies).
Fluorescence Microscopy--
Cells were processed for
fluorescence microscopy 24 h after transfection by fixation with
3% paraformaldehyde in phosphate-buffered saline for 20 min. To assay
for NPC association of GFP3-M fusion proteins (data not
shown, but see "Discussion"), cells were extracted first with 0.5%
Triton X-100 for 3 min and then fixed with paraformaldehyde for 20 min
(14). Fluorescent proteins were visualized using the ×100 objective of
an Axioplan 2 fluorescence microscope (Zeiss).
To score the nuclear localization of GFP3-M fusion
proteins, levels of fluorescence were quantified using Labworks Imaging Software (UVP, Inc). The ratio of average fluorescence in the nucleus
to average fluorescence in the cytoplasm over a defined region of three
representative cells was calculated and averaged for each protein. The
values (Navg/Cavg)avg < 1 were
scored as ( ) for nuclear localization. Values 1 < (Navg/Cavg)avg 1.2 and values
(Navg/Cavg)avg > 1.2 were scored
as (+) and (++), respectively.
 |
RESULTS |
M Protein Has an NLS within Amino Acids 47-229--
Since nuclear
localization is essential for the inhibitory activity of VSV M protein,
it is important to understand how this protein enters the nucleus. To
analyze the localization properties of M protein, we generated a fusion
protein that contains M protein and three tandem copies of
GFP3 and thus is much larger (~108 kDa) than the size
limit for diffusion (~60 kDa) through the NPC (4). Fusion proteins
were expressed in HeLa cells by transient transfection, and protein
localization was visualized in fixed cells by fluorescence microscopy.
The expressed GFP3 protein was stable in HeLa cells, as
indicated by the predominance of full-length protein (86% of total protein detected) in cell extracts analyzed by Western blotting (Fig.
1B, lane a). Localization of GFP3 was
almost exclusively cytoplasmic (Fig.
1A, panel a). In
contrast, the fusion protein containing M protein and GFP3
(GFP3-M-(1-229)), which was also stable when expressed in
HeLa cells (Fig. 1B, lane b), accumulated strongly in cell nuclei (Fig. 1A, panel b). In
addition, GFP3-M-(1-229) was visible at the nuclear rim,
consistent with previous reports (14, 15). The ability of M protein to
direct import of a cytoplasmic protein into the nucleus demonstrates
that M protein contains at least one NLS that is capable of mediating
active transport.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 1.
Mapping an NLS in the carboxyl-terminal
region of VSV M protein. A, HeLa cells were transiently
transfected with plasmid DNA encoding GFP3 (a)
or the indicated GFP3-M fusion proteins (b-e).
Protein localization was analyzed in fixed cells by fluorescence
microscopy. B, extracts from HeLa cells transiently
transfected with DNA encoding GFP3 (a),
GFP3-M-(1-229) (b),
GFP3-M-(47-229) (c),
GFP3-M-(57-229) (d), or GFP3-M
-(47-194) (e) were analyzed by Western blot using
monoclonal anti-GFP antibodies. Molecular weights, in kDa, are denoted
on the left. Typically, fusion proteins containing an active
version of M protein were expressed at lower levels (e.g.
panel b), probably due to inhibition of nucleocytoplasmic
transport (13) and/or transcription (32, 33). C, schematic
diagram of full-length and truncated GFP3-M fusion
proteins. Dark boxes represent the M protein sequences and
hatched boxes represent the three tandem GFP sequences. The
GFP3 region (~90 kDa) is not drawn to scale. The nuclear
localization of each protein was scored as described under
"Experimental Procedures" and in the legend for Table II, and
scores ((++) or ( )) are shown on the right.
|
|
To identify sequence(s) within M protein that function as an NLS, we
examined the localization of GFP3-M fusion proteins
containing truncated versions of M protein (diagrammed in Fig.
1C). An amino-terminal truncation was made to generate
GFP3-M-(47-229), based on previous reports of a stable
carboxyl-terminal fragment of M protein produced by trypsin digestion
(21, 22). Expressed GFP3-M-(47-229) was stable (Fig.
1B, lane c), and this protein accumulated in the nucleus (Fig. 1A, panel c), demonstrating that
amino acids 47-229 of M protein are sufficient for nuclear localization.
The NLS within M-(47-229) was defined further by making truncations
based on a computer-generated prediction of the secondary structure of
M protein (16). Sequence was deleted from either the amino- or
carboxyl-terminal ends of M-(47-229) to generate GFP3-M-(57-229) and GFP3-M-(47-194),
respectively. Although both expressed proteins were stable in HeLa
cells (Fig. 1B, lanes d and e),
neither protein accumulated in cell nuclei (Fig. 1A,
panels d and e). Thus, both amino- and
carboxyl-terminal sequences of M-(47-229) are necessary for function
of the NLS in this carboxyl-terminal region of M protein. We refer to
the NLS in M-(47-229) as NLS-C.
Trp-91 and Tyr-105 Are Important for the Function of NLS-C--
To
determine which amino acids are necessary for the function of NLS-C, we
made single alanine substitutions throughout
GFP3-M-(47-229) at the positions of residues conserved
among vesiculoviral M proteins (16) (Fig.
2A, numbered residues in
boldface), reasoning that amino acids important for protein
function are likely to be conserved. Single alanine substitutions were
also made at the positions of three carboxyl-terminal residues that are
not identically conserved (Fig. 2A, residues denoted by
asterisks), but which were previously implicated as being
important for the inhibition of cellular gene expression in
VSV-infected cells (23). For each mutant protein, levels of nuclear and
cytoplasmic fluorescence were quantified and scored (Table
II). Representative cells that were
scored as ( ) (Fig. 2B, panels a and
b), (+) (panel c), and (++) (panel d)
for nuclear localization are shown. The stabilities of all mutant
proteins were confirmed by Western blotting (data not shown).

View larger version (68K):
[in this window]
[in a new window]
|
Fig. 2.
Mutational analysis of NLS-C.
A, amino acids 47-229 of VSV M protein (Orsay strain).
Amino acids identified by sequence alignment (16) as being identical
among the M proteins of VSV, chandipura virus, spring viremia carp
virus and piry virus are numbered and highlighted in bold.
Asterisks denote carboxyl-terminal amino acids previously
implicated as being important for the inhibition of cellular gene
expression in VSV-infected cells (23). B, HeLa cells
transiently transfected with plasmid DNA encoding
GFP3-M-(47-229) containing the substitution W91A
(a), Y105A (b), G209A (c), or Y95A
(d) were analyzed as in Fig. 1. C, HeLa cells
transiently transfected with plasmid DNA encoding
GFP3-M-(47-229) containing the substitution Y105E
(a) or Y105F (b) were analyzed as in Fig.
1.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
The effects of single amino acid substitutions on nuclear localization
of GFP3-M-(47-229)
The ratio of average fluorescence in the nucleus to average
fluorescence in the cytoplasm over a defined region of three
representative cells was calculated and averaged for each mutant
(Labworks Imaging Software, UVP, Inc.). The values of
(Navg/Cavg)avg < 1 represent cytoplasmic
accumulation of fluorescence and are denoted as ( ). The values of
1 < (Navg/Cavg)avg 1.2 represent the
presence of nuclear fluorescence and are denoted as (+), and values of
(Navg/Cavg)avg > 1.2 represent strong nuclear
accumulation of fluorescence and are denoted as (++). Nuclear
localization of the wild-type versions of GFP3-M(1-229) and
GFP3-M-(47-229) were also quantified, and scores are shown in
Fig. 1C.
|
|
Of the 22 single alanine substitutions made in
GFP3-M-(47-229), 20 had little or no effect on nuclear
localization (Table II). However, when alanine substitutions were made
at positions 91 (W91A) or 105 (Y105A) in GFP3-M-(47-229),
the resulting mutant proteins accumulated in the cytoplasm (Fig.
2B, panels a and b), suggesting that these
residues are important for the function of NLS-C. We asked if
phosphorylation of Tyr-105 contributes to the function of NLS-C, since
it had previously been shown that M protein can be phosphorylated at
several Ser, Thr, and Tyr residues (24, 25). When Tyr-105 was replaced
by glutamic acid, to introduce a negative charge (mimicking
constitutive phosphorylation), the resulting protein (Y105E)
accumulated in the cytoplasm like Y105A (Fig. 2C,
panel a, compared with Fig. 2B, panel b);
conversely, replacement of Tyr-105 with Phe, which cannot be
phosphorylated, resulted in a protein (Y105F) that accumulated in the
nucleus (Fig. 2C, panel b) like wild-type
GFP3-M-(47-229) (Fig. 1A, panel c).
These results suggest that phosphorylation of Tyr-105 is not important
for the nuclear localization of M-(47-229), but that the presence of
an aromatic residue at position 105 is important.
Amino acids 47-229 Are Sufficient for the Inhibitory Activity of M
Protein--
Previous work by us (14, 16) and others (15, 17)
established a correlation between the abilities of M protein to
associate with NPCs and to inhibit nucleocytoplasmic transport. Since
GFP3-M-(47-229) was visible at the nuclear rim as well as
within the nucleoplasm (Fig. 1A, panel c), we
asked if M-(47-229) was active as an inhibitor of nucleocytoplasmic
transport. The inhibitory activity of M-(47-229) was assayed by
testing the ability of a chimeric protein (GST-HA-M(47-229)) to
inhibit RNA export in X. laevis oocytes (14). The
GST-HA-M-(47-229) protein inhibited export of snRNA and mRNA when
injected into oocyte nuclei (Fig. 3,
compare panel b with panel a) or cytoplasms (data
not shown). Therefore, M-(47-229) is sufficient for the inhibition of
nucleocytoplasmic transport.

View larger version (57K):
[in this window]
[in a new window]
|
Fig. 3.
Inhibitory activity of M-(47-229) wild-type,
W91A, and Y105A. Wild-type or mutant GST-HA-M-(47-229) protein
was injected into Xenopus oocyte nuclei 1 h before the
nuclear injection of RNA export substrates. Export of
32P-labeled U1Sm- snRNA, AdML mRNA, and
tRNA was monitored 1 and 3 h after RNA injection (18, 19). RNA
export was monitored in the absence (a) or in the presence
of GST-HA-M-(47-229) (wild-type) (b), GST-HA-M-(47-229)
(W91A) (c), or GST-HA-M-(47-229) (Y105A) (d).
The lane labeled T shows the total RNAs in the injection
mixture. Note that the small amount of U3 and pre-mRNA apparent in
the cytoplasm in panel d is most likely due to the
technically difficult manipulations required for oocyte injections and
dissections.
|
|
Trp-91 and Tyr-105 Are Not Required for the Inhibitory Activity of
M Protein--
The inhibitory activities of variants of
GST-HA-M-(47-229) containing W91A or Y105A substitutions were also
assayed for inhibitory activity in oocytes. Since GST-HA-M-(47-229) is
small enough (~52 kDa) to access the nucleus by diffusion, results
were the same when the mutant proteins were injected into either oocyte
nuclei or cytoplasms. Both mutant proteins inhibited snRNA and mRNA
export (Fig. 3, panels c and d, compared with
panel a), showing that Trp-91 and Tyr-105 are not necessary
for the inhibitory activity of M protein. In the presence of either
mutant protein, some snRNA and mRNA was detectable in the cytoplasm
at the second time point (Fig. 3, panels c and d,
far right lanes), indicating that these proteins may not be
as potent as the wild-type GST-HA-M-(47-229) protein. Thus, although
Trp-91 and Tyr-105 are important for the function of NLS-C in the
context of M-(47-229), they are not essential for the inhibitory
activity of M protein. We conclude that distinct amino acids in M
protein are required for inhibitory activity and for nuclear localization.
The Effect of W91A on the Function of NLS-C Is Suppressed in
Full-length M Protein--
We next examined the effects of W91A and
Y105A mutations on nuclear localization of the full-length M protein.
The expressed mutant proteins were both stable in HeLa cells (data not
shown). The presence of the amino-terminal 46 residues of M protein did not alter the effect of the Y105A mutation on nuclear localization, since GFP3-M-(1-229) (Y105A) accumulated mainly in the
cytoplasm (Fig. 4, panel c),
as did GFP3-M-(47-229) (Y105A) (Fig. 2B,
panel b). In contrast, addition of amino acids 1-46 to
GFP3-M-(47-229) (W91A) resulted in a protein,
GFP3-M-(1-229) (W91A), which localized predominantly
within the nucleus (Fig. 4, panel b). Thus, the effect of
the W91A mutation on the function of NLS-C is suppressed in the context
of full-length M protein, suggesting that amino acids 1-46 could
comprise an alternative NLS.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 4.
Differential effects of the W91A and Y105A
substitutions on nuclear localization of
GFP3-M-(1-229). HeLa cells transiently transfected
with plasmid DNA encoding GFP3-M-(1-229) (wild-type)
(a), GFP3-M-(1-229) (W91A) (b), or
GFP3-M-(1-229) (Y105A) (c) were analyzed as in
Fig. 1.
|
|
M Protein Has a Second, Novel NLS within Amino Acids
23-57--
To determine if the amino-terminal region of M protein
functions autonomously as an NLS, we examined the localization of
several GFP3-M fusion proteins (diagrammed in Fig.
5A), all of which were stable
when expressed in HeLa cells (data not shown). Although some
GFP3-M-(1-47) protein was observed in nuclei, it did not accumulate there (Fig. 5B, panel a). However, the
slightly larger fusion protein, GFP3-M-(1-57), did
accumulate in the nucleus (Fig. 5B, panel b),
indicating that a second NLS is contained within amino acids 1-57 of
the M protein.

View larger version (63K):
[in this window]
[in a new window]
|
Fig. 5.
Mapping an NLS in the
amino-terminal region of M protein. A, a schematic
representation of truncated GFP3-M fusion proteins, where
dark boxes represent the M protein sequence and
hatched boxes represent the GFP3 sequence. The
GFP3 region (~90 kDa) is not drawn to scale. The nuclear
localization of each protein was scored as described under
"Experimental Procedures" and in the legend for Table II, and
scores ((++), (+), or ( )) are shown on the right.
B, HeLa cells transiently transfected with plasmid DNA
encoding GFP3-M-(1-47) (a),
GFP3-M-(1-57) (b), GFP3-M-(23-57)
(c), or GFP3-M-(32-57) (d) were
analyzed as in Fig. 1. C, amino acid sequence of the
amino-terminal 57 residues of VSV M protein (Orsay strain). Amino acids
identified by sequence alignment (16) as being identical among M
proteins of VSV, chandipura virus, spring viremia carp virus and piry
virus are numbered and highlighted in bold. The region of M
protein that contains NLS-N is underlined. The sequence
common to the regions of M protein containing NLS-N and NLS-C is
underlined twice. HeLa cells transiently transfected with plasmid DNA
encoding GFP3-M-(23-57) (P25A) (a) or
GFP3-M-(23-57) (A39L) (b) were analyzed as in
Fig. 1.
|
|
To further define this NLS, amino-terminal truncations and alanine
substitutions were made. Unexpectedly, GFP3-M-(23-57), which lacks the highly basic amino-terminal region of M protein, also
accumulated in the nucleus (Fig. 5B, panel c).
When additional residues were removed from the N terminus of
M-(23-57), to generate GFP3-M-(32-57), nuclear
accumulation was abolished (Fig. 5B, panel d).
Thus, the amino-terminal NLS (NLS-N) is contained within amino acids
23-57 (Fig. 5C, underlined).
In the context of GFP3-M-(23-57), single alanine
substitutions (and one Ala to Leu substitution) were made at positions
that are conserved among the vesiculoviral M proteins (Fig.
5C, numbered residues in boldface). Three of the
six single amino acid substitutions reduced, but none abolished,
nuclear accumulation of GFP3-M-(23-57) (Table
III). Representative cells that were
scored as (+) (Fig. 5C, panel a) and (++)
(panel b) for nuclear localization are shown. The sequence
in M-(23-57) displays no striking homology to previously reported
NLSs, suggesting that NLS-N is a novel NLS.
View this table:
[in this window]
[in a new window]
|
Table III
The effects of single amino acid substitutions on nuclear localization
of GFP3-M-(23-57)
Values of (+) and (++) are assigned as described under "Experimental
Procedures" and in the legend for Table 2. Nuclear localization of
the wild-type version of GFP3-M-(23-57) was also quantified,
and the score is shown in Fig. 5A
|
|
 |
DISCUSSION |
We have shown that the M protein of VSV can be actively imported
into the nucleus, since it can direct nuclear accumulation of a large
cytoplasmic protein, GFP3, in transiently transfected HeLa
cells. Whereas it has previously been shown that M protein distributes
between the nucleus and the cytoplasm during VSV infection (26), the
mechanism by which M protein enters the nucleus was unclear. This work
demonstrates that, even though it is smaller than the diffusion limits
of the NPC, M protein is able to exploit cellular mechanisms for active
nuclear import. Perhaps active import allows for nuclear localization
that is more rapid and efficient than nuclear localization via simple diffusion.
The region of M protein containing NLS-N was mapped to amino acids
23-57. Interestingly, the highly basic region (amino acids 1-22) of M
protein, which resembles the classical NLSs of SV40 T antigen
(PKKKRKVE) and nucleoplasmin (KRPAATKKAGQAKKKKLD), was not required for
nuclear localization, nor does it function as an NLS when fused to
GFP3 (data not shown). While M-(23-57) has no apparent
similarity to published NLSs, it does contain two motifs,
PPXY (amino acids 24-27 of M protein) and
P(T/S)XP (amino acids 37-40 of M protein), that can each
bind WW domain-containing proteins, including members of the Nedd 4 family of E3 ubiquitin ligases (27, 28, 29). Since it has recently been
shown that Nedd 4 is a nucleocytoplasmic-shuttling protein (30), it is plausible that NLS-N could promote nuclear import via a piggyback mechanism, bound to a WW domain-containing protein, such as a Nedd 4 family member. This model is consistent with our inability to abolish
the function of NLS-N with a single alanine substitution, since each
individual motif would be capable of independently binding a WW
domain-containing protein.
A second NLS was mapped to amino acids 47-229. NLS-C appears to be
rather complex, in that amino acids located at its amino- and
carboxyl-terminal ends are necessary for nuclear import. These sequences could promote nuclear localization either directly, by
interacting with one or more cellular proteins, or indirectly, by
contributing to the proper folding of M protein. In addition to
elements at the amino- and carboxyl-terminal ends of M-(47-229), conserved amino acids at positions 91 and 105 are also important for
the function of NLS-C, since the amino acid substitutions W91A and
Y105A abolished nuclear accumulation of GFP3-M-(47-229). Importantly, these substitutions did not destroy the ability of M
protein to inhibit transport, indicating that there is no gross misfolding of the mutant proteins.
Some insight into the organization of NLS-C can be gained from the
recently solved crystal structure of a fragment of M protein containing
amino acids 48-229 (31). From this work, it is clear that both Trp-91
and Tyr-105 are buried residues that are not exposed at the surface of
the protein, so they are likely to contribute to the maintenance of a
specific structural motif important for the function of NLS-C. The
contributions of the amino- and carboxyl-terminal regions of
M-(47-229) to the organization of NLS-C are less obvious. While the
amino-terminal region of the crystal structure (amino acids 48-58) is
disordered, the carboxyl terminus is exposed and lies along the surface
of the protein. It is unclear whether the impaired nuclear localization
of GFP3-M-(47-194) (Fig. 1A, panel e) arises from structural changes induced by deletion of the
carboxyl-terminal 35 residues or from the absence of one or more
specific residues in this region that is recognized by a cellular
protein required for nuclear localization. Further mutational analysis
of this region, based on information from the crystal structure, may be helpful in distinguishing between these possibilities.
In addition to containing NLS-C, M-(47-229) is also sufficient for the
inhibition of nucleocytoplasmic transport. Moreover, consistent with
previous findings that transport inhibition activity correlates with
NPC association (14, 15, 17), M-(47-229) is sufficient for association
with NPCs (nuclear rim staining visible in Fig. 1A,
panel c). Within M-(47-229), two amino acids, Trp-91 and Tyr-105,
were shown to be important for nuclear localization (Fig. 2), but not
for inhibitory activity (Fig. 3) or association with NPCs (data not
shown). Conversely, the alanine substitution of Met-51, a residue
previously shown to be essential for inhibitory activity (14, 15),
reduced, but did not abolish, nuclear localization in the context of
either M-(47-229) or M-(23-57) (Tables II and III). Moreover, in the
context of M-(1-229), the M51A substitution had no detectable effect
on nuclear localization (data not shown), as was previously shown for
an M51L substitution (16). Thus, Met-51 is an amino acid in M protein
that is essential for inhibitory activity (14, 15) but is not required
for nuclear localization. We conclude that distinct amino acids in M
protein are required for nuclear localization and for inhibitory activity.
In the context of full-length M protein, it is unclear whether NLS-N
and NLS-C can function independently or whether they work together.
Both NLSs require a common region of M protein (M-(47-57)) for their
function, but this region is not sufficient for nuclear localization,
since neither GFP3-M-(32-57) (Fig. 5B, panel d) nor GFP3-M-(47-194) (Fig.
1A, panel e) accumulated in the nucleus.
Therefore, additional sequences unique to each NLS are essential for
function. Curiously, even though our data indicate that M-(23-57)
contains an NLS that can function autonomously and that can overcome
the deleterious effects of W91A on nuclear localization, we observed a
lack of nuclear accumulation of GFP3-M-(1-229) (Y105A).
Thus, in the context of full-length M protein, Tyr-105 could be
important for both NLSs to work together efficiently.
Why might M protein contain multiple NLSs? The presence of multiple
NLSs has been observed in several viral, as well as cellular, proteins
(35-37). Perhaps more than one NLS is present in M protein to ensure
efficient entry into the nucleus by active import. Different cellular
proteins bound to both NLSs could work cooperatively during nuclear
import of the full length M protein. It will be interesting to learn
which cellular proteins recognize the NLSs of VSV M protein to mediate
its nuclear localization.
 |
ACKNOWLEDGEMENTS |
We thank Yuri Lazebnik for kindly supplying
the vector encoding GFP3. We also thank Elsebet Lund and
Christopher Trotta for discussions and critical comments on the
manuscript, and Corey Slominski for technical assistance.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant GM-30220 (to J. E. D.) and a Burroughs Wellcome Fund of the Life Sciences Research Foundation fellowship (to J. M. P.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: Bacterial Zoonoses Branch, Division of
Vector-Borne Infectious Diseases, Centers for Disease Control, 1300 Rampart Rd, Ft. Collins, CO 80521.
§
To whom correspondence should be addressed: Dept. of Biomolecular
Chemistry, University of Wisconsin-Madison, 1300 University Ave.,
Madison, WI 53706-1532. Tel.: 608-262-1459; Fax: 608-262-8704; E-mail:
dahlberg@facstaff.wisc.edu.
Published, JBC Papers in Press, September 25, 2002, DOI 10.1074/jbc.M208576200
 |
ABBREVIATIONS |
The abbreviations used are:
NPC, nuclear pore
complex;
NLS, nuclear localization signal;
M, matrix protein;
VSV, vesicular stomatitis virus;
HA, hemagglutinin;
GST, glutathione
S-transferase;
GFP, green fluorescent protein;
Nup, nucleoporin.
 |
REFERENCES |
| 1.
|
Ryan, K. J.,
and Wente, S. R.
(2000)
Curr. Opin. Cell Biol.
12,
361-371[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Rout, M. P.,
and Aitchison, J. D.
(2001)
J. Biol. Chem.
276,
16593-16596[Free Full Text]
|
| 3.
|
Macara, I. G.
(2001)
Microbiol. Mol. Biol. Rev.
65,
570-594[Abstract/Free Full Text]
|
| 4.
|
Görlich, D.,
and Kutay, U.
(1999)
Annu. Rev. Cell Dev. Biol.
15,
607-660[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Dahlberg, J. E.,
and Lund, E.
(1998)
Curr. Opin. Cell Biol.
10,
400-408[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Baake, M.,
Doenecke, D.,
and Albig, W.
(2001)
J. Cell. Biochem.
81,
333-346[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Turpin, P.,
Hay, R. T.,
and Dargemont, C.
(1999)
J. Biol. Chem.
274,
6804-6812[Abstract/Free Full Text]
|
| 8.
|
Mattaj, I. W.,
and Englmeier, L.
(1998)
Annu. Rev. Biochem.
67,
265-306[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Fan, X. C.,
and Steitz, J. A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
15293-15298[Abstract/Free Full Text]
|
| 10.
|
Siomi, H.,
and Dreyfuss, G.
(1995)
J. Cell Biol.
129,
551-560[Abstract/Free Full Text]
|
| 11.
|
Michael, W. M.,
Eder, P. S.,
and Dreyfuss, G.
(1997)
EMBO J.
16,
3587-3598[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Makkerh, J. P. S.,
Dingwall, C.,
and Laskey, R. A.
(1996)
Curr. Biol.
6,
1025-1027[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Her, L.-S.,
Lund, E.,
and Dahlberg, J. E.
(1997)
Science
276,
1845-1848[Abstract/Free Full Text]
|
| 14.
|
Petersen, J. M.,
Her, L.-S.,
Varvel, V.,
Lund, E.,
and Dahlberg, J. E.
(2000)
Mol. Cell. Biol.
20,
8590-8601[Abstract/Free Full Text]
|
| 15.
|
von Kobbe, C.,
van Deursen, J. M.,
Rodrigues, J. P.,
Sitterlin, D.,
Bachi, A., Wu, X.,
Wilm, M.,
Carmo-Fonseca, M.,
and Izaurralde, E.
(2000)
Mol. Cell
6,
1243-1252[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Petersen, J. M.,
Her, L.-S.,
and Dahlberg, J. E.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
8590-8595[Abstract/Free Full Text]
|
| 17.
|
Enninga, J.,
Levy, D. E.,
Blobel, G.,
and Fontoura, B. M. A.
(2002)
Science
295,
1523-1525[Abstract/Free Full Text]
|
| 18.
|
Pasquinelli, A. E.,
Dahlberg, J. E.,
and Lund, E.
(1995)
RNA
1,
957-967[Abstract]
|
| 19.
|
Terns, M. P.,
and Dahlberg, J. E.
(1994)
Science
264,
959-961[Abstract/Free Full Text]
|
| 20.
|
Grimm, C.,
Lund, E.,
and Dahlberg, J. E.
(1997)
EMBO J.
16,
793-806[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Morrison, T. G.,
and McQuain, C. O.
(1978)
J. Virol.
26,
115-125[Abstract/Free Full Text]
|
| 22.
|
Pal, R.,
Grinnell, B. W.,
Snyder, R. M.,
Wiener, J. R.,
Volk, W. A.,
and Wagner, R. R.
(1985)
J. Virol.
55,
298-306[Abstract/Free Full Text]
|
| 23.
|
Desforges, M.,
Charron, J.,
Bérard, S.,
Beausoleil, S.,
Stojdl, D. F.,
Despars, G.,
Laverdière, B.,
Bell, J. C.,
Talbot, P. J.,
Stanners, C. P.,
and Poliquin, L.
(2001)
Virus Res.
76,
87-102[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Clinton, G. M.,
and Huang, A. S.
(1981)
Virology
108,
510-514[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Kaptur, P. E.,
McCreedy, B. J., Jr.,
and Lyles, D. S.
(1992)
J. Virol.
66,
5384-5392[Abstract/Free Full Text]
|
| 26.
|
Lyles, D. S.,
Puddington, L.,
and McCreedy, B. J., Jr.
(1988)
J. Virol.
62,
4387-4392[Abstract/Free Full Text]
|
| 27.
|
Harty, R. N.,
Paragas, J.,
Sudol, M.,
and Palese, P.
(1999)
J. Virol.
73,
2921-2929[Abstract/Free Full Text]
|
| 28.
|
Harty, R. N.,
Brown, M. E.,
Wang, G.,
Huibregtse, J.,
and Hayes, F. P.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
13871-13876[Abstract/Free Full Text]
|
| 29.
|
Strack, B.,
Calistri, A.,
Accola, M. A.,
Palù, G.,
and Göttlinger, H. G.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
13063-13068[Abstract/Free Full Text]
|
| 30.
|
Hamilton, M. H.,
Tcherepanova, I.,
Huibregtse, J. M.,
and McDonnell, D. P.
(2001)
J. Biol. Chem.
276,
26324-26331[Abstract/Free Full Text]
|
| 31.
|
Gaudier, M.,
Gaudin, Y.,
and Knossow, M.
(2002)
EMBO J.
21,
2886-2892[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Black, B. L.,
and Lyles, D. S.
(1992)
J. Virol.
66,
4058-4064[Abstract/Free Full Text]
|
| 33.
|
Paik, S. Y.,
Banerjee, A. C.,
Harmison, G. G.,
Chen, S. J.,
and Schuber, M.
(1995)
J. Virol.
69,
3529-3537[Abstract]
|
| 34.
|
Wagner, R. R.
(1987)
The Rhabdoviruses
, pp. 9-74, Plenum Publishing Corp., New York
|
| 35.
|
Segref, A.,
Mattaj, I. W.,
and Ohno, M.
(2001)
RNA
3,
351-360
|
| 36.
|
Schwamborn, K.,
Albig, W.,
and Doenecke, D.
(1998)
Exp. Cell Res.
244,
206-217[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Jenkins, Y.,
McEntee, M.,
Weis, K.,
and Greene, W. C.
(1998)
J. Cell Biol.
143,
875-885[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Li, J. S. Chorba, and S. P. J. Whelan
Vesicular Stomatitis Viruses Resistant to the Methylase Inhibitor Sinefungin Upregulate RNA Synthesis and Reveal Mutations That Affect mRNA Cap Methylation
J. Virol.,
April 15, 2007;
81(8):
4104 - 4115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. D. Lichty, H. McBride, S. Hanson, and J. C. Bell
Matrix protein of Vesicular stomatitis virus harbours a cryptic mitochondrial-targeting motif.
J. Gen. Virol.,
November 1, 2006;
87(Pt 11):
3379 - 3384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Nesic, G. Tanackovic, and A. Kramer
A role for Cajal bodies in the final steps of U2 snRNP biogenesis
J. Cell Sci.,
September 1, 2004;
117(19):
4423 - 4433.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|